首页 > 最新文献

Experimental cell research最新文献

英文 中文
Localisation and organisation of the focal adhesion kinase FAK1 and Simiate inside nuclear speckles. 核斑内黏附激酶FAK1的定位和组织。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-28 DOI: 10.1016/j.yexcr.2026.114907
Regina Dahlhaus, Ralf J Braun

The development of a well-organised genome represents a hallmark in the evolution of species. In mammals, the nucleus of each cell is characterised by the presence of different compartments, among others nuclear speckles, membrane-less organelles that are self-shaped by liquid droplet-like phase separation. Functioning in the organisation of the transcription and splicing machinery, nuclear speckles are highly dynamic, moving and rearranging within the nucleus according to the needs of the cell. In line with a role of actin dynamics in speckle function, we could previously demonstrate that the actin-binding protein Simiate is not only enriched in nuclear speckles, but also able to associate with nuclear isoforms of the Focal Adhesion Kinase FAK1. Furthermore, nuclear speckles have recently been suggested to consist of specific sub-domains involved in the spatial organisation of chromatin handling and mRNA processing. In this study, we therefore examined the sub-speckular organisation of FAK1 and Simiate in mouse brain slices using three-dimensional reconstructions and stimulated emission depletion (STED) microscopy. While FAK1 is predominantly localised in peripheral areas, Simiate is highly enriched in the core domain. Aside, Simiate is also seen in the surrounding shell, and minor amounts of FAK1 are detected in the core domain. As the number of speckles increases, FAK1 is found to diminish from the core domain, whereas peripheral numbers remain constant. Both proteins, Simiate and FAK1, are organised in spherical clusters, which may occasionally colocalise in peripheral as well as core domains. Although our data obtained from mouse brain slices are merely descriptive, they may suggest for dynamic rearrangement of FAK1.

组织良好的基因组的发展是物种进化的一个标志。在哺乳动物中,每个细胞核的特征是存在不同的隔室,其中包括核斑点,通过液滴状相分离形成的无膜细胞器。核斑点在转录和剪接机制的组织中起作用,是高度动态的,根据细胞的需要在细胞核内移动和重新排列。根据肌动蛋白动力学在斑点功能中的作用,我们之前可以证明肌动蛋白结合蛋白模拟不仅在核斑点中富集,而且能够与Focal Adhesion Kinase FAK1的核同工型相关联。此外,核斑点最近被认为由参与染色质处理和mRNA加工的空间组织的特定子结构域组成。本研究使用三维重建和受激发射损耗(STED)显微镜检查了小鼠脑切片中FAK1和类似物的亚斑组织。FAK1主要位于外围区域,而simate则高度富集于核心区域。除此之外,在周围的外壳中也可以看到类似蛋白,在核心区域中检测到少量的FAK1。随着斑点数量的增加,FAK1在核心区域减少,而外围区域数量保持不变。虽然我们从小鼠脑切片中获得的数据仅仅是描述性的,但它们可能提示FAK1的动态重排。这两种蛋白,模拟蛋白和FAK1蛋白,都被组织成球形簇,它们偶尔会在外围和核心区域共定位。
{"title":"Localisation and organisation of the focal adhesion kinase FAK1 and Simiate inside nuclear speckles.","authors":"Regina Dahlhaus, Ralf J Braun","doi":"10.1016/j.yexcr.2026.114907","DOIUrl":"10.1016/j.yexcr.2026.114907","url":null,"abstract":"<p><p>The development of a well-organised genome represents a hallmark in the evolution of species. In mammals, the nucleus of each cell is characterised by the presence of different compartments, among others nuclear speckles, membrane-less organelles that are self-shaped by liquid droplet-like phase separation. Functioning in the organisation of the transcription and splicing machinery, nuclear speckles are highly dynamic, moving and rearranging within the nucleus according to the needs of the cell. In line with a role of actin dynamics in speckle function, we could previously demonstrate that the actin-binding protein Simiate is not only enriched in nuclear speckles, but also able to associate with nuclear isoforms of the Focal Adhesion Kinase FAK1. Furthermore, nuclear speckles have recently been suggested to consist of specific sub-domains involved in the spatial organisation of chromatin handling and mRNA processing. In this study, we therefore examined the sub-speckular organisation of FAK1 and Simiate in mouse brain slices using three-dimensional reconstructions and stimulated emission depletion (STED) microscopy. While FAK1 is predominantly localised in peripheral areas, Simiate is highly enriched in the core domain. Aside, Simiate is also seen in the surrounding shell, and minor amounts of FAK1 are detected in the core domain. As the number of speckles increases, FAK1 is found to diminish from the core domain, whereas peripheral numbers remain constant. Both proteins, Simiate and FAK1, are organised in spherical clusters, which may occasionally colocalise in peripheral as well as core domains. Although our data obtained from mouse brain slices are merely descriptive, they may suggest for dynamic rearrangement of FAK1.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114907"},"PeriodicalIF":3.5,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MT1E binds to LncRNA NEAT1 to regulate SLC39A14-mediated ferroptosis in the pathogenesis of aortic dissection. MT1E结合LncRNA NEAT1调控slc39a14介导的主动脉夹层铁上沉的发病机制
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-27 DOI: 10.1016/j.yexcr.2026.114906
Changbo Xiao, Zihe Zheng, Mingliang Li, Quanlin Yang, Xiaofu Dai

Background: Aortic dissection (AD) is a life-threatening vascular disease whose pathogenesis involves dysfunction of vascular smooth muscle cells (VSMCs) and cell death. This study aimed to investigate the role of the MT1E/LncRNA NEAT1/SLC39A14 axis in AD and its molecular mechanism in regulating ferroptosis.

Methods: The correlation between ferroptosis and AD was evaluated using single-sample gene set enrichment analysis (ssGSEA). Weighted gene co-expression network analysis (WGCNA) based on the GSE153434 dataset was performed to identify key modules. Differentially expressed genes were screened through GO, KEGG enrichment analyses, and protein-protein interaction (PPI) network analysis. The functions and interactions of MT1E, LncRNA NEAT1, and SLC39A14 were validated using RT-PCR, Western Blot, immunohistochemistry, Co-IP assay, RIP assay, and luciferase reporter assays. A mouse model was constructed to evaluate the role of MT1E in AD pathological injury and ferroptosis.

Results: AD was significantly associated with ferroptosis. WGCNA identified a blue module highly correlated with ferroptosis, and 236 differentially expressed genes were screened. MT1E, LncRNA NEAT1, and SLC39A14 were significantly upregulated in aortic tissues of AD patients. Knockdown of MT1E inhibited AngII-induced VSMC proliferation, migration, and ferroptosis, and restored the expression of VSMC phenotypic transformation markers. MT1E activates NEAT1 expression by forming a complex with YBX1, while MT1E activates NEAT1 through zinc ion release-mediated regulation of SFPQ and NONO. Besides, luciferase reporter assays demonstrated the direct binding of LncRNA NEAT1 to SLC39A14. Overexpression of LncRNA NEAT1 reversed the inhibitory effects of MT1E knockdown on VSMC proliferation, migration, and ferroptosis. Overexpression of SLC39A14 counteracted the effects of MT1E or LncRNA NEAT1 knockdown on VSMCs. Mouse model experiments validated the critical role of MT1E in AD pathological injury and ferroptosis.

Conclusion: This study reveals that MT1E plays a pivotal role in AD by targeting LncRNA NEAT1 to regulate SLC39A14-mediated ferroptosis. These findings provide novel insights into the molecular mechanisms of AD and offer potential therapeutic targets for related diseases.

背景:主动脉夹层(Aortic dissection, AD)是一种危及生命的血管疾病,其发病机制涉及血管平滑肌细胞功能障碍和细胞死亡。本研究旨在探讨MT1E/LncRNA NEAT1/SLC39A14轴在AD中的作用及其调控铁凋亡的分子机制。方法:采用单样本基因集富集分析(ssGSEA)评价铁下垂与AD的相关性。基于GSE153434数据集进行加权基因共表达网络分析(Weighted gene co-expression network analysis, WGCNA),识别关键模块。通过GO、KEGG富集分析和蛋白蛋白相互作用(PPI)网络分析筛选差异表达基因。MT1E、LncRNA NEAT1和SLC39A14的功能和相互作用通过RT-PCR、Western Blot、免疫组织化学、Co-IP测定、RIP测定和荧光素酶报告基因测定进行验证。建立小鼠模型,探讨MT1E在AD病理性损伤和铁下垂中的作用。结果:AD与铁下垂有显著相关性。WGCNA鉴定出一个与铁下垂高度相关的蓝色模块,并筛选了236个差异表达基因。MT1E、LncRNA NEAT1、SLC39A14在AD患者主动脉组织中表达显著上调。敲低MT1E可抑制血管内皮素诱导的VSMC增殖、迁移和铁下垂,恢复VSMC表型转化标志物的表达。MT1E通过与YBX1形成复合物激活NEAT1表达,而MT1E通过锌离子释放介导的SFPQ和NONO调控激活NEAT1。此外,荧光素酶报告基因检测显示LncRNA NEAT1与SLC39A14直接结合。LncRNA NEAT1的过表达逆转了MT1E敲低对VSMC增殖、迁移和铁下垂的抑制作用。SLC39A14的过表达抵消了MT1E或LncRNA NEAT1敲低对vsmc的影响。小鼠模型实验验证了MT1E在AD病理性损伤和铁下垂中的重要作用。结论:本研究揭示MT1E通过靶向LncRNA NEAT1调控slc39a14介导的铁ptosis在AD中发挥关键作用。这些发现为阿尔茨海默病的分子机制提供了新的见解,并为相关疾病提供了潜在的治疗靶点。
{"title":"MT1E binds to LncRNA NEAT1 to regulate SLC39A14-mediated ferroptosis in the pathogenesis of aortic dissection.","authors":"Changbo Xiao, Zihe Zheng, Mingliang Li, Quanlin Yang, Xiaofu Dai","doi":"10.1016/j.yexcr.2026.114906","DOIUrl":"10.1016/j.yexcr.2026.114906","url":null,"abstract":"<p><strong>Background: </strong>Aortic dissection (AD) is a life-threatening vascular disease whose pathogenesis involves dysfunction of vascular smooth muscle cells (VSMCs) and cell death. This study aimed to investigate the role of the MT1E/LncRNA NEAT1/SLC39A14 axis in AD and its molecular mechanism in regulating ferroptosis.</p><p><strong>Methods: </strong>The correlation between ferroptosis and AD was evaluated using single-sample gene set enrichment analysis (ssGSEA). Weighted gene co-expression network analysis (WGCNA) based on the GSE153434 dataset was performed to identify key modules. Differentially expressed genes were screened through GO, KEGG enrichment analyses, and protein-protein interaction (PPI) network analysis. The functions and interactions of MT1E, LncRNA NEAT1, and SLC39A14 were validated using RT-PCR, Western Blot, immunohistochemistry, Co-IP assay, RIP assay, and luciferase reporter assays. A mouse model was constructed to evaluate the role of MT1E in AD pathological injury and ferroptosis.</p><p><strong>Results: </strong>AD was significantly associated with ferroptosis. WGCNA identified a blue module highly correlated with ferroptosis, and 236 differentially expressed genes were screened. MT1E, LncRNA NEAT1, and SLC39A14 were significantly upregulated in aortic tissues of AD patients. Knockdown of MT1E inhibited AngII-induced VSMC proliferation, migration, and ferroptosis, and restored the expression of VSMC phenotypic transformation markers. MT1E activates NEAT1 expression by forming a complex with YBX1, while MT1E activates NEAT1 through zinc ion release-mediated regulation of SFPQ and NONO. Besides, luciferase reporter assays demonstrated the direct binding of LncRNA NEAT1 to SLC39A14. Overexpression of LncRNA NEAT1 reversed the inhibitory effects of MT1E knockdown on VSMC proliferation, migration, and ferroptosis. Overexpression of SLC39A14 counteracted the effects of MT1E or LncRNA NEAT1 knockdown on VSMCs. Mouse model experiments validated the critical role of MT1E in AD pathological injury and ferroptosis.</p><p><strong>Conclusion: </strong>This study reveals that MT1E plays a pivotal role in AD by targeting LncRNA NEAT1 to regulate SLC39A14-mediated ferroptosis. These findings provide novel insights into the molecular mechanisms of AD and offer potential therapeutic targets for related diseases.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114906"},"PeriodicalIF":3.5,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overexpression of biliverdin reductase A leads to ROS-independent sensitization of ovarian adenocarcinoma cells to gemcitabine 胆绿素还原酶A的过度表达导致卵巢腺癌细胞对吉西他滨不依赖ros的致敏。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-23 DOI: 10.1016/j.yexcr.2026.114905
Zuzana Solárová , Kristína Danková , Pavol Harvanik , Peter Bober , Petra Majerová , Radka Michalková , Mangesh Bhide , Peter Solár

Aims

Biliverdin reductase A (BLVRA) is a key enzyme in bilirubin metabolism, where it reduces biliverdin to bilirubin. Bilirubin is a potent antioxidant that protects cells from oxidative stress. Therefore, reduced or deregulated BLVRA activity may contribute to increased oxidative DNA damage, which is one of the factors leading to the neoplastic transformation of cells.

Methods

Human ovarian adenocarcinoma A2780 cells were transfected with a PiggyBac vector to achieve BLVRA overexpression. A2780 clones showing the most significant BLVRA gene overexpression were analyzed by proteomics and flow cytometry to assess rective oxygen species (ROS) production.

Results

Our results indicate that BLVRA overexpression increases the sensitivity of A2780 cells to doxorubicin and gemcitabine, with the most pronounced effect observed in the J clone. In this clone, the highest level of BLVRA overexpression correlated with significant alterations in the p53 signaling pathway. Upregulation of key effectors such as Bax and CDKN2A indicates a potential role for BLVRA in promoting pro-apoptotic responses. Moreover, BLVRA overexpression increased the sensitivity of A2780 cells to gemcitabine independently of ROS.

Conclusions

This study broadens our understanding of BLVRA in ovarian cancer. In cells with intact p53 signaling, BLVRA overexpression can paradoxically enhance cytotoxic response to certain drugs, particularly gemcitabine.
目的:胆绿素还原酶A (BLVRA)是胆红素代谢的关键酶,可将胆绿素还原为胆红素。胆红素是一种有效的抗氧化剂,可以保护细胞免受氧化应激。因此,BLVRA活性降低或失调可能导致DNA氧化损伤增加,这是导致细胞肿瘤转化的因素之一。方法:用PiggyBac载体转染人卵巢腺癌A2780细胞,实现BLVRA过表达。通过蛋白质组学和流式细胞术分析显示BLVRA基因过表达最显著的A2780克隆,以评估活性氧(ROS)的产生。结果:我们的研究结果表明,BLVRA过表达增加了A2780细胞对阿霉素和吉西他滨的敏感性,其中在J克隆中观察到的效果最为明显。在该克隆中,BLVRA过表达的最高水平与p53信号通路的显著改变相关。关键效应因子如Bax和CDKN2A的上调表明BLVRA在促进促凋亡反应中的潜在作用。此外,BLVRA过表达增加了A2780细胞对吉西他滨的敏感性,而不依赖于ROS。结论:本研究拓宽了我们对卵巢癌中BLVRA的认识。在p53信号完整的细胞中,BLVRA过表达可以矛盾地增强对某些药物的细胞毒性反应,特别是吉西他滨。
{"title":"Overexpression of biliverdin reductase A leads to ROS-independent sensitization of ovarian adenocarcinoma cells to gemcitabine","authors":"Zuzana Solárová ,&nbsp;Kristína Danková ,&nbsp;Pavol Harvanik ,&nbsp;Peter Bober ,&nbsp;Petra Majerová ,&nbsp;Radka Michalková ,&nbsp;Mangesh Bhide ,&nbsp;Peter Solár","doi":"10.1016/j.yexcr.2026.114905","DOIUrl":"10.1016/j.yexcr.2026.114905","url":null,"abstract":"<div><h3>Aims</h3><div>Biliverdin reductase A (BLVRA) is a key enzyme in bilirubin metabolism, where it reduces biliverdin to bilirubin. Bilirubin is a potent antioxidant that protects cells from oxidative stress. Therefore, reduced or deregulated BLVRA activity may contribute to increased oxidative DNA damage, which is one of the factors leading to the neoplastic transformation of cells.</div></div><div><h3>Methods</h3><div>Human ovarian adenocarcinoma A2780 cells were transfected with a PiggyBac vector to achieve BLVRA overexpression. A2780 clones showing the most significant BLVRA gene overexpression were analyzed by proteomics and flow cytometry to assess rective oxygen species (ROS) production.</div></div><div><h3>Results</h3><div>Our results indicate that BLVRA overexpression increases the sensitivity of A2780 cells to doxorubicin and gemcitabine, with the most pronounced effect observed in the J clone. In this clone, the highest level of BLVRA overexpression correlated with significant alterations in the p53 signaling pathway. Upregulation of key effectors such as Bax and CDKN2A indicates a potential role for BLVRA in promoting pro-apoptotic responses. Moreover, <em>BLVRA</em> overexpression increased the sensitivity of A2780 cells to gemcitabine independently of ROS.</div></div><div><h3>Conclusions</h3><div>This study broadens our understanding of BLVRA in ovarian cancer. In cells with intact p53 signaling, BLVRA overexpression can paradoxically enhance cytotoxic response to certain drugs, particularly gemcitabine.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 2","pages":"Article 114905"},"PeriodicalIF":3.5,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CDC6 promotes keratinocyte senescence through the CCND1/P53 signaling in ischemia-reperfusion injury-induced pressure injury 在缺血再灌注损伤诱导的压力损伤中,CDC6通过CCND1/P53信号通路促进角质细胞衰老。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.yexcr.2026.114903
Chenming Wang , Shanshan Zhu , Meige Dai , Hui Chen
Pressure injuries develop when prolonged compression of the skin and subcutaneous tissue impairs blood circulation, leading to localized tissue ischemia, degeneration, and ultimately necrosis. Ischemia-reperfusion(I/R) injury is one of the key pathological mechanisms underlying pressure injury formation. While cellular senescence has been implicated in I/R-related pathologies, its role in pressure injury development remains unclear. We aimed to elucidate the mechanisms of keratinocyte senescence in cutaneous I/R injury. An in vitro hypoxia/reoxygenation (H/R) model was employed to simulate I/R injury using human immortalized keratinocytes (HaCaT). H/R induction significantly exacerbated the senescence response, as characterized by reduced cell proliferation, increased apoptosis, elevated SA-β-galactosidase (SA-β-gal) activity, and upregulated expression of senescence markers (p16 and p21). Quantitative proteomic analysis identified CDC6 as a prominently upregulated protein under H/R conditions. siRNA-mediated CDC6 knockdown attenuated keratinocyte senescence, restored G1/S phase cyclin-D1 (CCND1) expression, and suppressed p53 levels, demonstrating its regulatory role in senescence via the p53/CCND1 pathway. Furthermore, protein interaction network analysis and experimental validation revealed CDC6's direct binding with origin recognition complex 2 (ORC2), evidenced by nuclear colocalization (immunofluorescence) and physical interaction (co-immunoprecipitation). Collectively, our findings pioneers the mechanistic elucidation of CDC6 in pressure injury pathology, proposing senescence-targeted interventions as a novel therapeutic strategy for ulcer management.
当长期压迫皮肤和皮下组织损害血液循环,导致局部组织缺血、变性和最终坏死时,就会发生压伤。缺血再灌注(I/R)损伤是压力性损伤形成的重要病理机制之一。虽然细胞衰老与I/ r相关病理有关,但其在压力损伤发展中的作用尚不清楚。我们旨在阐明皮肤I/R损伤中角质细胞衰老的机制。采用体外缺氧/再氧合(H/R)模型模拟人永生化角质形成细胞(HaCaT)的I/R损伤。H/R诱导显著加剧了衰老反应,表现为细胞增殖减少,凋亡增加,SA-β-半乳糖苷酶(SA-β-gal)活性升高,衰老标志物(p16和p21)表达上调。定量蛋白质组学分析发现CDC6是H/R条件下显著上调的蛋白。sirna介导的CDC6敲低可减弱角质形成细胞衰老,恢复G1/S期cyclin-D1 (CCND1)表达,抑制p53水平,表明其通过p53/CCND1通路调控衰老。此外,蛋白质相互作用网络分析和实验验证表明,CDC6通过核共定位(免疫荧光)和物理相互作用(共免疫沉淀)直接结合起源识别复合物2 (ORC2)。总的来说,我们的发现开创了CDC6在压力性损伤病理中的机制阐明,提出了针对衰老的干预措施作为溃疡管理的一种新的治疗策略。
{"title":"CDC6 promotes keratinocyte senescence through the CCND1/P53 signaling in ischemia-reperfusion injury-induced pressure injury","authors":"Chenming Wang ,&nbsp;Shanshan Zhu ,&nbsp;Meige Dai ,&nbsp;Hui Chen","doi":"10.1016/j.yexcr.2026.114903","DOIUrl":"10.1016/j.yexcr.2026.114903","url":null,"abstract":"<div><div>Pressure injuries develop when prolonged compression of the skin and subcutaneous tissue impairs blood circulation, leading to localized tissue ischemia, degeneration, and ultimately necrosis. Ischemia-reperfusion(I/R) injury is one of the key pathological mechanisms underlying pressure injury formation. While cellular senescence has been implicated in I/R-related pathologies, its role in pressure injury development remains unclear. We aimed to elucidate the mechanisms of keratinocyte senescence in cutaneous I/R injury. An in vitro hypoxia/reoxygenation (H/R) model was employed to simulate I/R injury using human immortalized keratinocytes (HaCaT). H/R induction significantly exacerbated the senescence response, as characterized by reduced cell proliferation, increased apoptosis, elevated SA-β-galactosidase (SA-β-gal) activity, and upregulated expression of senescence markers (p16 and p21). Quantitative proteomic analysis identified CDC6 as a prominently upregulated protein under H/R conditions. siRNA-mediated CDC6 knockdown attenuated keratinocyte senescence, restored G1/S phase cyclin-D1 (CCND1) expression, and suppressed p53 levels, demonstrating its regulatory role in senescence via the p53/CCND1 pathway. Furthermore, protein interaction network analysis and experimental validation revealed CDC6's direct binding with origin recognition complex 2 (ORC2), evidenced by nuclear colocalization (immunofluorescence) and physical interaction (co-immunoprecipitation). Collectively, our findings pioneers the mechanistic elucidation of CDC6 in pressure injury pathology, proposing senescence-targeted interventions as a novel therapeutic strategy for ulcer management.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 2","pages":"Article 114903"},"PeriodicalIF":3.5,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “A human tissue-based model of renal inflammation” [Exp. Cell Res. 2024 Nov 1;443(1):114309] “基于人体组织的肾脏炎症模型”的勘误表[实验细胞杂志,2024年11月1日;443(1):114309]。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-21 DOI: 10.1016/j.yexcr.2026.114896
Camilla Merrild , Gitte A. Pedersen , Kristian W. Antonsen , Mia G. Madsen , Anna K. Keller , Holger J. Møller , Lene N. Nejsum , Henricus A.M. Mutsaers , Rikke Nørregaard
{"title":"Corrigendum to “A human tissue-based model of renal inflammation” [Exp. Cell Res. 2024 Nov 1;443(1):114309]","authors":"Camilla Merrild ,&nbsp;Gitte A. Pedersen ,&nbsp;Kristian W. Antonsen ,&nbsp;Mia G. Madsen ,&nbsp;Anna K. Keller ,&nbsp;Holger J. Møller ,&nbsp;Lene N. Nejsum ,&nbsp;Henricus A.M. Mutsaers ,&nbsp;Rikke Nørregaard","doi":"10.1016/j.yexcr.2026.114896","DOIUrl":"10.1016/j.yexcr.2026.114896","url":null,"abstract":"","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 2","pages":"Article 114896"},"PeriodicalIF":3.5,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PLA2R1-mediated ERK-Dependent ferroptosis: A key pathogenic mechanism in epileptic neuronal injury pla2r1介导的erk依赖性铁凋亡:癫痫性神经元损伤的关键致病机制。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-20 DOI: 10.1016/j.yexcr.2026.114904
Hong Chen , Guohang Wu , Qiannan Song

Background

Phospholipase A2 receptor 1 (PLA2R1) plays a regulatory role in pathological processes, but its mechanism in epileptic neuronal injury remains unclear. This study aimed to elucidate how PLA2R1 promotes epileptic neuronal injury through ERK-dependent ferroptosis.

Methods

A kainic acid-induced epilepsy mouse model was employed. PLA2R1 expression was detected using qRT-PCR, Western blot, and immunofluorescence. PLA2R1 knockdown and overexpression vectors were constructed to observe effects on seizure severity and neuronal injury. Ferroptosis indicators (GPX4, ACSL4, PTGS2, MDA, ROS, GSH) were analyzed. HT22 cells were used for in vitro validation with glutamate and Erastin-induced ferroptosis. ERK pathway involvement was verified using inhibitor SCH772984.

Results

PLA2R1 was upregulated in epileptic tissues. PLA2R1 knockdown prolonged seizure latency, reduced seizure intensity, decreased neuronal injury, and inhibited ERK activation. It upregulated GPX4 and GSH while downregulating ACSL4, PTGS2, MDA, and ROS. PLA2R1 overexpression exacerbated ferroptosis-related neuronal injury. In vitro experiments confirmed that ferroptosis inducers upregulated PLA2R1, while knockdown improved neuronal survival. ERK inhibitor SCH772984 reversed PLA2R1 overexpression-induced neuronal injury.

Conclusion

This study identified the PLA2R1-MEK-ERK-ferroptosis signaling axis, suggesting that PLA2R1 contributes to neuronal ferroptosis through ERK pathway activation in epilepsy. PLA2R1's druggability and ERK inhibitors' clinical safety provide foundation for therapeutic translation.
背景:磷脂酶A2受体1 (PLA2R1)在病理过程中起调节作用,但其在癫痫性神经元损伤中的机制尚不清楚。本研究旨在阐明PLA2R1如何通过erk依赖性铁下垂促进癫痫性神经元损伤。方法:采用凯尼克酸致痫小鼠模型。采用qRT-PCR、Western blot和免疫荧光检测PLA2R1的表达。构建PLA2R1敲低和过表达载体,观察其对癫痫发作严重程度和神经元损伤的影响。分析铁下垂指标(GPX4、ACSL4、PTGS2、MDA、ROS、GSH)。HT22细胞用于谷氨酸和erastin诱导的铁下垂的体外验证。使用抑制剂SCH772984验证ERK通路参与。结果:PLA2R1在癫痫组织中表达上调。PLA2R1敲除延长癫痫发作潜伏期,降低癫痫发作强度,减少神经元损伤,抑制ERK激活。上调GPX4和GSH,下调ACSL4、PTGS2、MDA和ROS。PLA2R1过表达加重了铁凋亡相关的神经元损伤。体外实验证实,铁下垂诱导剂上调PLA2R1,而下调可改善神经元存活。ERK抑制剂SCH772984逆转PLA2R1过表达诱导的神经元损伤。结论:本研究确定了PLA2R1- mek -ERK-铁下垂信号轴,提示PLA2R1通过ERK通路激活参与癫痫神经元铁下垂。PLA2R1的可药物性和ERK抑制剂的临床安全性为治疗性翻译提供了基础。
{"title":"PLA2R1-mediated ERK-Dependent ferroptosis: A key pathogenic mechanism in epileptic neuronal injury","authors":"Hong Chen ,&nbsp;Guohang Wu ,&nbsp;Qiannan Song","doi":"10.1016/j.yexcr.2026.114904","DOIUrl":"10.1016/j.yexcr.2026.114904","url":null,"abstract":"<div><h3>Background</h3><div>Phospholipase A2 receptor 1 (PLA2R1) plays a regulatory role in pathological processes, but its mechanism in epileptic neuronal injury remains unclear. This study aimed to elucidate how PLA2R1 promotes epileptic neuronal injury through ERK-dependent ferroptosis.</div></div><div><h3>Methods</h3><div>A kainic acid-induced epilepsy mouse model was employed. PLA2R1 expression was detected using qRT-PCR, Western blot, and immunofluorescence. PLA2R1 knockdown and overexpression vectors were constructed to observe effects on seizure severity and neuronal injury. Ferroptosis indicators (GPX4, ACSL4, PTGS2, MDA, ROS, GSH) were analyzed. HT22 cells were used for in vitro validation with glutamate and Erastin-induced ferroptosis. ERK pathway involvement was verified using inhibitor SCH772984.</div></div><div><h3>Results</h3><div>PLA2R1 was upregulated in epileptic tissues. PLA2R1 knockdown prolonged seizure latency, reduced seizure intensity, decreased neuronal injury, and inhibited ERK activation. It upregulated GPX4 and GSH while downregulating ACSL4, PTGS2, MDA, and ROS. PLA2R1 overexpression exacerbated ferroptosis-related neuronal injury. In vitro experiments confirmed that ferroptosis inducers upregulated PLA2R1, while knockdown improved neuronal survival. ERK inhibitor SCH772984 reversed PLA2R1 overexpression-induced neuronal injury.</div></div><div><h3>Conclusion</h3><div>This study identified the PLA2R1-MEK-ERK-ferroptosis signaling axis, suggesting that PLA2R1 contributes to neuronal ferroptosis through ERK pathway activation in epilepsy. PLA2R1's druggability and ERK inhibitors' clinical safety provide foundation for therapeutic translation.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 1","pages":"Article 114904"},"PeriodicalIF":3.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146017988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upregulation of Gfi1 induced by LSD1 inhibitor protects against cisplatin-induced ototoxicity through attenuating pyroptosis LSD1抑制剂诱导的Gfi1上调通过减轻焦亡保护顺铂诱导的耳毒性
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-19 DOI: 10.1016/j.yexcr.2026.114902
Zihe Zhao , Jingjing Luo , Dengbin Ma , Siyu Li , Shaoqin Cen , Hanqi Fan , Zhenxing Hou , Junze Lu , Cheng Cheng , Xiaoyun Qian , Xia Gao , Ao Li
Cisplatin, a widely used chemotherapeutic agent, is associated with significant ototoxicity. Identifying potential therapeutic targets to mitigate cisplatin-induced hearing loss has become a crucial goal. In this study, we demonstrated that the LSD1 inhibitor S2101 could protect against cisplatin-induced ototoxicity (CIO) by upregulating Gfi1 expression. Mechanistically, we investigated the regulatory relationship between Gfi1 and Trim27. Our findings indicated that Gfi1 could bind to the Trim27 promoter region, activating its transcription. The subsequent upregulation of Trim27 significantly attenuated hair cell pyroptosis, highlighting the therapeutic potential of the Gfi1-Trim27 pathway. These results collectively underscore the critical function of Gfi1 in protecting against cisplatin-induced hearing loss and provide novel insights into potential therapeutic strategies.
顺铂是一种广泛使用的化疗药物,具有显著的耳毒性。确定潜在的治疗靶点以减轻顺铂引起的听力损失已成为关键目标。在这项研究中,我们证明LSD1抑制剂S2101可以通过上调Gfi1的表达来保护顺铂诱导的耳毒性(CIO)。在机制上,我们研究了Gfi1和Trim27之间的调控关系。我们的研究结果表明,Gfi1可以结合到Trim27启动子区域,激活其转录。随后Trim27的上调显著减轻了毛细胞焦亡,突出了Gfi1-Trim27通路的治疗潜力。这些结果共同强调了Gfi1在预防顺铂性听力损失方面的关键功能,并为潜在的治疗策略提供了新的见解。
{"title":"Upregulation of Gfi1 induced by LSD1 inhibitor protects against cisplatin-induced ototoxicity through attenuating pyroptosis","authors":"Zihe Zhao ,&nbsp;Jingjing Luo ,&nbsp;Dengbin Ma ,&nbsp;Siyu Li ,&nbsp;Shaoqin Cen ,&nbsp;Hanqi Fan ,&nbsp;Zhenxing Hou ,&nbsp;Junze Lu ,&nbsp;Cheng Cheng ,&nbsp;Xiaoyun Qian ,&nbsp;Xia Gao ,&nbsp;Ao Li","doi":"10.1016/j.yexcr.2026.114902","DOIUrl":"10.1016/j.yexcr.2026.114902","url":null,"abstract":"<div><div>Cisplatin, a widely used chemotherapeutic agent, is associated with significant ototoxicity. Identifying potential therapeutic targets to mitigate cisplatin-induced hearing loss has become a crucial goal. In this study, we demonstrated that the LSD1 inhibitor S2101 could protect against cisplatin-induced ototoxicity (CIO) by upregulating Gfi1 expression. Mechanistically, we investigated the regulatory relationship between Gfi1 and Trim27. Our findings indicated that Gfi1 could bind to the Trim27 promoter region, activating its transcription. The subsequent upregulation of Trim27 significantly attenuated hair cell pyroptosis, highlighting the therapeutic potential of the Gfi1-Trim27 pathway. These results collectively underscore the critical function of Gfi1 in protecting against cisplatin-induced hearing loss and provide novel insights into potential therapeutic strategies.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 2","pages":"Article 114902"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146017972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AHNAK inhibits osteoporosis progression by stabilizing Smad1 protein AHNAK通过稳定Smad1蛋白抑制骨质疏松症进展。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-17 DOI: 10.1016/j.yexcr.2026.114899
Weifei Zhang , Hua Chen , Tiantian Qi , Dengbo Yao , Hang Liu , Hui Zeng , Fei Yu , Wenyu Zhou
AHNAK is a structural scaffold protein implicated in a wide array of physiological functions. AHNAK mutations are highly prevalent in patients with osteoporosis, However, it is currently unknown whether AHNAK affects the progression of osteoporosis and the specific mechanism behind this effect. This study detected decreased AHNAK (AHNAK1) expression in bone tissues and bone marrow mesenchymal stem cells (BMSCs) of osteoporotic mice. Genetic knockdown of AHNAK inhibited osteogenic differentiation of BMSCs. Mechanistic investigations indicated that AHNAK functions through stabilizing Smad1 protein levels. Overexpression of Smad1 in AHNAK-knockdown BMSCs restored their osteogenic differentiation capacity. Furthermore, in vivo mouse experiments further confirmed these findings. Collectively, these findings indicate that AHNAK inhibits the progression of osteoporosis by stabilizing Smad1 protein.
AHNAK是一种结构支架蛋白,涉及广泛的生理功能。AHNAK突变在骨质疏松症患者中非常普遍,然而,目前尚不清楚AHNAK是否影响骨质疏松症的进展以及这种影响背后的具体机制。本研究检测到骨质疏松小鼠骨组织和骨髓间充质干细胞(BMSCs)中AHNAK (AHNAK1)表达降低。基因敲低AHNAK抑制骨髓间充质干细胞成骨分化。机制研究表明AHNAK通过稳定Smad1蛋白水平发挥作用。在ahnak缺失的骨髓间充质干细胞中,Smad1的过表达恢复了它们的成骨分化能力。此外,小鼠体内实验进一步证实了这些发现。总的来说,这些发现表明AHNAK通过稳定Smad1蛋白来抑制骨质疏松症的进展。
{"title":"AHNAK inhibits osteoporosis progression by stabilizing Smad1 protein","authors":"Weifei Zhang ,&nbsp;Hua Chen ,&nbsp;Tiantian Qi ,&nbsp;Dengbo Yao ,&nbsp;Hang Liu ,&nbsp;Hui Zeng ,&nbsp;Fei Yu ,&nbsp;Wenyu Zhou","doi":"10.1016/j.yexcr.2026.114899","DOIUrl":"10.1016/j.yexcr.2026.114899","url":null,"abstract":"<div><div>AHNAK is a structural scaffold protein implicated in a wide array of physiological functions. AHNAK mutations are highly prevalent in patients with osteoporosis, However, it is currently unknown whether AHNAK affects the progression of osteoporosis and the specific mechanism behind this effect. This study detected decreased AHNAK (AHNAK1) expression in bone tissues and bone marrow mesenchymal stem cells (BMSCs) of osteoporotic mice. Genetic knockdown of AHNAK inhibited osteogenic differentiation of BMSCs. Mechanistic investigations indicated that AHNAK functions through stabilizing Smad1 protein levels. Overexpression of Smad1 in AHNAK-knockdown BMSCs restored their osteogenic differentiation capacity. Furthermore, in vivo mouse experiments further confirmed these findings. Collectively, these findings indicate that AHNAK inhibits the progression of osteoporosis by stabilizing Smad1 protein.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 2","pages":"Article 114899"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
USP18 promotes cell proliferation and inhibits ferroptosis by stabilizing HDAC3 in endometrial carcinoma USP18通过稳定HDAC3促进子宫内膜癌细胞增殖和抑制铁下垂。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-15 DOI: 10.1016/j.yexcr.2026.114900
Fang Tong , Xue Gao , Yuhong Shang
Endometrial cancer (EC) represents one of the most prevalent malignancies of the female reproductive system. Ferroptosis, a recently identified form of programmed cell death, has garnered increasing attention in cancer research. Ubiquitin-specific peptidase 18 (USP18), a member of the deubiquitinating enzyme family, has been recognized as an oncoprotein in various cancers; however, its functional role and underlying mechanisms in EC remain largely unexplored. In this study, we found that USP18 was markedly upregulated in EC patients (n = 15, stage I; n = 4, stage II and n = 1, stage III), and elevated USP18 expression correlated with unfavorable prognosis. Functional assays demonstrated that knockdown of USP18 significantly inhibited EC cell proliferation. Moreover, USP18 silencing promoted the accumulation of lipid reactive oxygen species (ROS), malondialdehyde (MDA), and Fe2+, thereby enhancing erastin-induced ferroptosis. In contrast, USP18 overexpression produced opposing effects. These in vitro findings were further validated in vivo, where USP18 knockdown suppressed tumor growth and promoted ferroptosis. Mechanistic investigations revealed that USP18 interacted with and deubiquitinated histone deacetylase 3 (HDAC3), thus leading to its stabilization. Subsequent rescue experiments confirmed that the tumor-promoting effects of USP18 were abrogated upon HDAC3 knockdown. Taken together, our results identify the USP18/HDAC3 axis as a key regulator of EC cell proliferation and ferroptosis suppression, underscoring the potential of USP18 as a therapeutic target in EC.
子宫内膜癌(EC)是女性生殖系统最常见的恶性肿瘤之一。铁下垂是最近发现的一种程序性细胞死亡形式,在癌症研究中引起了越来越多的关注。泛素特异性肽酶18 (USP18)是去泛素化酶家族的一员,已被认为是多种癌症的癌蛋白;然而,其在EC中的功能作用和潜在机制在很大程度上仍未被探索。在本研究中,我们发现USP18在EC患者中显著上调(n=15,一期;n=4,二期;n=1,ⅲ期),USP18表达升高与不良预后相关。功能分析表明,敲低USP18可显著抑制EC细胞的增殖。此外,USP18沉默促进了脂质活性氧(ROS)、丙二醛(MDA)和Fe2+的积累,从而增强了erastin诱导的铁下沉。相反,USP18过表达产生相反的效果。这些体外研究结果在体内得到进一步验证,其中USP18敲低抑制肿瘤生长并促进铁下垂。机制研究表明,USP18与组蛋白去乙酰化酶3 (HDAC3)相互作用并去泛素化,从而导致其稳定。随后的抢救实验证实,HDAC3敲低后,USP18的促瘤作用被消除。综上所述,我们的研究结果确定了USP18/HDAC3轴是EC细胞增殖和铁凋亡抑制的关键调节因子,强调了USP18作为EC治疗靶点的潜力。
{"title":"USP18 promotes cell proliferation and inhibits ferroptosis by stabilizing HDAC3 in endometrial carcinoma","authors":"Fang Tong ,&nbsp;Xue Gao ,&nbsp;Yuhong Shang","doi":"10.1016/j.yexcr.2026.114900","DOIUrl":"10.1016/j.yexcr.2026.114900","url":null,"abstract":"<div><div>Endometrial cancer (EC) represents one of the most prevalent malignancies of the female reproductive system. Ferroptosis, a recently identified form of programmed cell death, has garnered increasing attention in cancer research. Ubiquitin-specific peptidase 18 (USP18), a member of the deubiquitinating enzyme family, has been recognized as an oncoprotein in various cancers; however, its functional role and underlying mechanisms in EC remain largely unexplored. In this study, we found that USP18 was markedly upregulated in EC patients (n = 15, stage I; n = 4, stage II and n = 1, stage III), and elevated USP18 expression correlated with unfavorable prognosis. Functional assays demonstrated that knockdown of USP18 significantly inhibited EC cell proliferation. Moreover, USP18 silencing promoted the accumulation of lipid reactive oxygen species (ROS), malondialdehyde (MDA), and Fe<sup>2+</sup>, thereby enhancing erastin-induced ferroptosis. In contrast, USP18 overexpression produced opposing effects. These in vitro findings were further validated <em>in vivo</em>, where USP18 knockdown suppressed tumor growth and promoted ferroptosis. Mechanistic investigations revealed that USP18 interacted with and deubiquitinated histone deacetylase 3 (HDAC3), thus leading to its stabilization. Subsequent rescue experiments confirmed that the tumor-promoting effects of USP18 were abrogated upon HDAC3 knockdown. Taken together, our results identify the USP18/HDAC3 axis as a key regulator of EC cell proliferation and ferroptosis suppression, underscoring the potential of USP18 as a therapeutic target in EC.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 1","pages":"Article 114900"},"PeriodicalIF":3.5,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion Src对EphA2的上调可抵消Src诱导的细胞粘附丧失。
IF 3.5 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2026-01-14 DOI: 10.1016/j.yexcr.2026.114898
Misuzu Takada , Mayu Murata , Shuhei Soeda , Takuya Honda , Ryuzaburo Yuki , Yuji Nakayama
The receptor tyrosine kinase EphA2 is highly expressed in various cancers, and its elevated levels are associated with poor prognosis. Although Src has been shown to increase EphA2 expression partly through ERK signaling, the functional consequences of EphA2 upregulation remain unclear. In this study, we investigated the role of EphA2 upregulation by active Src in cell adhesion. We utilized HeLa S3-derived HeLa S3/v-Src cells, which allow inducible v-Src expression upon doxycycline (Dox) treatment. Dox treatment induced v-Src expression, cell rounding, and a marked increase in global tyrosine phosphorylation. Consistent with previously reports, EphA2 expression was upregulated following v-Src induction. Time-course analysis revealed that EphA2 knockdown accelerated v-Src-induced cell rounding. Similarly, c-Src also upregulated EphA2 and induced cell rounding. Paxillin staining demonstrated that c-Src expression increased both the number and area of focal adhesions, as well as paxillin intensity at these sites. All of these effects were abolished by EphA2 knockdown. In conclusion, Src activity upregulates EphA2 expression, and increased EphA2 counteracts Src-induced cell detachment. However, as Src signaling intensifies, it overrides the counteracting effect of EphA2, resulting in cell rounding and detachment. The balance between Src and EphA2 may act as a key regulator of cellular adhesion dynamics.
酪氨酸激酶受体EphA2在多种癌症中高表达,其水平升高与预后不良相关。尽管Src已被证明部分通过ERK信号传导增加EphA2的表达,但EphA2上调的功能后果尚不清楚。在本研究中,我们研究了活性Src上调EphA2在细胞粘附中的作用。我们利用HeLa S3衍生的HeLa S3/v-Src细胞,在多西环素(Dox)处理下可诱导v-Src表达。Dox处理诱导了v-Src表达、细胞圆缩和整体酪氨酸磷酸化的显著增加。与先前的报道一致,v-Src诱导后EphA2表达上调。时间过程分析显示,EphA2敲低加速了v- src诱导的细胞圆弧。同样,c-Src也上调EphA2并诱导细胞圆缩。Paxillin染色显示c-Src的表达增加了病灶黏附的数量和面积,以及这些部位的Paxillin强度。所有这些影响都被EphA2敲除。综上所述,Src活性上调EphA2的表达,EphA2的升高抵消了Src诱导的细胞脱离。然而,随着Src信号的增强,它会覆盖EphA2的抵消作用,导致细胞变圆和脱离。Src和EphA2之间的平衡可能是细胞粘附动力学的关键调节因子。
{"title":"Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion","authors":"Misuzu Takada ,&nbsp;Mayu Murata ,&nbsp;Shuhei Soeda ,&nbsp;Takuya Honda ,&nbsp;Ryuzaburo Yuki ,&nbsp;Yuji Nakayama","doi":"10.1016/j.yexcr.2026.114898","DOIUrl":"10.1016/j.yexcr.2026.114898","url":null,"abstract":"<div><div>The receptor tyrosine kinase EphA2 is highly expressed in various cancers, and its elevated levels are associated with poor prognosis. Although Src has been shown to increase EphA2 expression partly through ERK signaling, the functional consequences of EphA2 upregulation remain unclear. In this study, we investigated the role of EphA2 upregulation by active Src in cell adhesion. We utilized HeLa S3-derived HeLa S3/v-Src cells, which allow inducible v-Src expression upon doxycycline (Dox) treatment. Dox treatment induced v-Src expression, cell rounding, and a marked increase in global tyrosine phosphorylation. Consistent with previously reports, EphA2 expression was upregulated following v-Src induction. Time-course analysis revealed that EphA2 knockdown accelerated v-Src-induced cell rounding. Similarly, c-Src also upregulated EphA2 and induced cell rounding. Paxillin staining demonstrated that c-Src expression increased both the number and area of focal adhesions, as well as paxillin intensity at these sites. All of these effects were abolished by EphA2 knockdown. In conclusion, Src activity upregulates EphA2 expression, and increased EphA2 counteracts Src-induced cell detachment. However, as Src signaling intensifies, it overrides the counteracting effect of EphA2, resulting in cell rounding and detachment. The balance between Src and EphA2 may act as a key regulator of cellular adhesion dynamics.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"456 1","pages":"Article 114898"},"PeriodicalIF":3.5,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental cell research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1